# Pertussis Vaccination in Pregnant Women

> **NCT03909126** · PHASE4 · COMPLETED · sponsor: **St. Justine's Hospital** · enrollment: 946 (actual)

## Conditions studied

- Pertussis

## Interventions

- **BIOLOGICAL:** Boostrix administered during gestational diabetes screening
- **BIOLOGICAL:** Boostrix administered in high volume obstetric clinic

## Key facts

- **NCT ID:** NCT03909126
- **Lead sponsor:** St. Justine's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-01
- **Primary completion:** 2021-05-30
- **Final completion:** 2021-05-30
- **Target enrollment:** 946 (ACTUAL)
- **Last updated:** 2021-09-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03909126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03909126, "Pertussis Vaccination in Pregnant Women". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT03909126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*